Dynamics of molecular response in AML patients with NPM1 and FLT3 mutations undergoing allogeneic stem cell transplant

被引：2
|
作者：
Salem, R. [1 ,2 ]
Massoud, R. [1 ,2 ]
Haffar, B. [1 ,2 ]
Mahfouz, R. [3 ]
Bazarbachi, A. [1 ,2 ]
El-Cheikh, J. [1 ,2 ]
机构：
[1] Amer Univ Beirut, Med Ctr, Bone Marrow Transplantat Program, Beirut, Lebanon
[2] Amer Univ Beirut, Med Ctr, Div Hematol & Oncol, Dept Internal Med, Beirut, Lebanon
[3] Amer Univ Beirut, Dept Pathol & Lab Med, Beirut, Lebanon
来源：
BONE MARROW TRANSPLANTATION | 2017年 / 52卷 / 08期
关键词：
ACUTE MYELOID-LEUKEMIA; MINIMAL RESIDUAL DISEASE; NUCLEOPHOSMIN;
D O I：
10.1038/bmt.2017.82
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1187 / 1190
页数：4
相关论文
共 50 条
  • [21] FLT3 INTERNAL TANDEM DUPLICATION AND NPM1 MUTATIONS IN PAEDIATRIC AML: A SINGLE CENTRE EXPERIENCE
    Gupta, V.
    Bourne, D.
    Bown, N.
    Samarasinghe, S.
    Bailey, S.
    Skinner, R.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S203 - S203
  • [22] Influence of FLT3-ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML
    Pasic, Ivan
    Da'na, Waleed
    Lam, Wilson
    Law, Arjun
    Lipton, Jeffrey
    Viswabandya, Auro
    Kim, Dennis
    Thyagu, Santhosh
    Messner, Hans
    Michelis, Fotios
    BONE MARROW TRANSPLANTATION, 2018, 53 : 169 - 170
  • [23] PROGNOSTIC SIGNIFICANCE OF FLT3 AND NPM1 MUTATIONS IN MYELOID MALIGNANCIES
    Olim, P.
    Sousa, P.
    Goncalves, A.
    Mesquita, L.
    Breda Coimbra, H.
    Moucho, C.
    Cortesao, E.
    Espadana, A.
    Carda, J.
    Pereira, M.
    Rito, L.
    Geraldes, C.
    Magalhaes, E.
    Sousa, I.
    Afonso, R.
    Gomes, M.
    Teixeira, A.
    Sarmento Ribeiro, A.
    HAEMATOLOGICA, 2012, 97 : 631 - 632
  • [24] Influence of FLT3-ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML
    Pasic, Ivan
    Da'na, Waleed
    Lam, Wilson
    Law, Arjun
    Lipton, Jeffrey H.
    Viswabandya, Auro
    Kim, Dennis D.
    Thyagu, Santhosh
    Messner, Hans A.
    Michelis, Fotios V.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (04) : 368 - 374
  • [25] FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India
    Ghosh, Kanjaksha
    Swaminathan, Suchitra
    Madkaikar, Manisha
    Gupta, Maya
    Kerketta, Lily
    Vundinti, Baburao
    ANNALS OF HEMATOLOGY, 2012, 91 (11) : 1703 - 1712
  • [26] FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India
    Kanjaksha Ghosh
    Suchitra Swaminathan
    Manisha Madkaikar
    Maya Gupta
    Lily Kerketta
    Baburao Vundinti
    Annals of Hematology, 2012, 91 : 1703 - 1712
  • [27] Prognostic Impact of FLT3 Mutation Load in NPM1 Mutated AML
    Schnittger, Susanne
    Weiss, Tamara
    Haferlach, Claudia
    Kern, Wolfgang
    Haferlach, Torsten
    BLOOD, 2009, 114 (22) : 341 - 341
  • [28] Response: Allogeneic stem cell transplantation and FLT3/ITD status in AML
    Gale, Rosemary E.
    Hills, Robert
    Wheatley, Keith
    Burnett, Alan K.
    Linch, David C.
    BLOOD, 2006, 108 (01) : 400 - 401
  • [29] Use of FLT3 Inhibitors to Bridge Relapsed/Refractory AML Patients to an Allogeneic Stem Cell Transplant
    Canaani, Jonathan
    Frey, Noelle V.
    Gill, Saar
    Luskin, Marlise R.
    Hexner, Elizabeth O.
    Loren, Alison W.
    Luger, Selina M.
    Mangan, James
    Porter, David L.
    Perl, Alexander E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S199 - S200
  • [30] "Cup-like" blasts and NPM1 and FLT3 (ITD) mutations in acute myeloid leukemia (AML)
    Jain, Preetesh
    Vega-Vazquez, Francisco
    Faderl, Stefan
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (01) : 3 - 3
12345